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The  availability  of  inbred  murine  strains  (NZB,  NZB/W,  BXSB,  MRL)  that 
spontaneously  develop  an  autoimmune  disease  resembling  human  systemic  lupus 
erythematosus (SLE), x enables one to study the preclinical stage of this disorder,  to 
discern possible common etiologic pathways for its development among these strains, 
and to manipulate them experimentally so as to determine their essential immunologic 
abnormalities. In terms of evaluating the latter abnormalities, MRL and BXSB mice 
(1)  are preferable to the NZB/W strain in that they express commonplace histocom- 
patibility  types  (NZB/W,  H-2a+z;  MRL, H-2*;  BXSB,  H-2  b)  and  offer both  acute 
severe and chronic late-life forms of SLE within  each strain  (1-3).  Thereby, trans- 
plantation of various organs and cell types between animals with acute and late-life 
SLE is possible unimpeded by antigenic differences between graft and host. 
Histopathologically,  all  of  the  immunologically  abnormal  strains  cited  above 
exhibit early thymic atrophy, most severe in the cortex, but also involving the medulla 
(2).  This finding,  as well as thymie hormonal  defects  (4,  5)  and premature thymic 
involution  with  prominent  degeneration  and  vacuolization of epithelial  cells  (6,  7) 
observed in New Zealand (NZ) mice, suggests a role for the thymus in the pathogenesis 
of murine  SLE.  Nevertheless,  until  recently,  no  definitive  experiments  have  been 
performed to  substantiate  the  postulated  role of the  thymus  in  the  disease  of this 
strain or in murine SLE in general. 
In the present studies, we have exchanged thymic transplants between the congenic 
MRL/Mp-lpr/lpr  and MRL/Mp-+/+  substrains to clarify whether inherent thymic 
defects contribute to the early appearance of severe SLE-like disease and massive T 
cell proliferation in the former (50% mortality in males and females at ~5-6 mo) but 
not  in  the  latter  substrain  (50%  mortality  at  17-23  mo  for  female  and  males, 
respectively).  Our  results  indicate  that,  although  a  thymus  is  necessary  for  the 
lymphoid hyperplasia and early SLE of lpr/lpr mice, the thymie genotype is irrelevent 
because the abnormal immunologic characteristics develop regardless of whether the 
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thymus is of lpr/lpr or +/+  genotype. Conversely, a  thymus of the lpr/lpr genotype 
does not confer early, severe SLE or lymphoproliferation to the +/+  mouse. 
Materials and Methods 
Mice.  MRL/Mp-lpr/lpr  and MRL/Mp-+/+  mice originally developed by Murphy and 
Roths (1) were bred and maintained at the Scripps Mouse Colony, Scripps Clinic and Research 
Foundation, La Jolla, Calif. All mice used in these experiments were females.  Experimental 
and control animals were housed identically and allowed standard laboratory food and water 
ad lib. Mice were followed daily for signs of disease,  lymphadenopathy, and survival and were 
bled monthly by retroorbital sinus puncture for serologic examinations. 
Thymectomy.  The following five  groups of mice were studied:  (a)  MRL/Mp-lpr/lpr  mice 
thymectomized when newborn (1-d old) and not transplanted with thymus; (b) MRL/Mp-lpr/ 
lpr mice thymectomized when newborn and transplanted at 1 mo of age with MRL/Mp-+/+ 
thymus; (c) MRL/Mp-+/+ mice thymectomized when newborn and transplanted at 1 mo of 
age  with  MRL/Mp-lpr/lpr  thymus;  (d)  control  unmanipulated MRL/Mp-lpr/lpr;  and  (e) 
control, unmanipulated MRL/Mp-+/+ mice. Thymeetomy was  performed through a  small 
longitudinal incision over the sternum, and the  thymus was withdrawn by a  wire loop  as 
described previously (8). In transplanted animals, a whole thymus from a  1-mo old donor was 
grafted under the skin at the back of the neck of the recipient by using a  19-gauge needle (8). 
Apart from histologic examinations, the absence or presence of a  thymus in thymectomized 
and thymus-transplanted animals was judged at 3 mo of age by determining the frequency of 
Thy-l.2  + cells in peripheral blood, number of plaque-forming cells in spleens, and the titer of 
hemagglutinating antibodies 5 d after intravenous immunization with 2 ×  108 sheep erythro- 
cytes  (SRBC)--a T  dependent antigen. Additionally, proliferative responses to  the  T  cell 
mitogens concanavalin A (Con A) and phytohemagglutinin (PHA) were examined in spleno- 
cytes of five mice from each of these groups. Representative results are shown in Table I. Mice 
that were considered incompletely thymectomized or not reconstituted (-20%) were discarded 
and not included in the results given below. 
Histologic Studies.  Unless otherwise indicated, mice were killed when moribund and then 
autopsied. Sections of thymuses, spleens, mesenteric and peripheral lymph nodes, and kidneys 
were fixed in Bouin's fluid and stained with hematoxylin and eosin and periodic aeid-Schiff 
stain. Severity of glomerulonephritis was graded from 0 to 4  + as described previously (2). 
Serologic Studies.  Blood urea nitrogen (BUN) was determined by Azostix strips as recom- 
mended by the manufacturer (Ames Division, Miles Laboratories, Inc., Elkhart, Ind.). IgG was 
estimated by single radial immunodiffusion (9). Anti-single-strand DNA (ssDNA)  and anti- 
double-strand DNA (dsDNA) antibodies were measured by a modified Farr assay as described 
(10). The modified Raji cell assay (2) was used for detecting immune complexes in murine sera. 
Serum retroviral envelope gp70 was measured by a radioimmunoassay (11). 
Cellular Analyses.  Spleen and lymph node cell preparations, total spleen and lymph node 
cell counting, cell viability determinations, and assessment of surface-Ig-bearing and Thy-l.2 
TABLE  I 
Mitogeni¢ Stimulation and Responses to SRBC In Thymectomized and Thymus-transplanted MRL Mice* 
Thy-1.2  +  Con A  PHA  SRBC  PFC:]:/  SRBC-aggluti- 
106 cells  nation titer 
% 
lpr/lpr (unmanipulated  67 
+/+ (unmanipulated)  59 
lpr/lpr (no implant)  9 
+/+ thymus--* lpr/lpr Tx§  51 
lpr/lpr thymus ~  +/+ Tx  41 
stimulation index 
7.5  4.2  237  32 
17.3  7.0  567  128 
1.7  1.2  13  2 
4.9  3.7  117  16 
8.6  5.2  421  64 
* Animals were tested at 3 mo of age. 
PFC, plaque-forming cells. 
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alloantigen-bearing cells were done as before (12, 13). Proliferative responses  to Con A and 
PHA were assessed after incubation for 3 d of triplicate cultures containing 2 x  105 splenocytes 
in microtiter plates with 0.25 #g and 100 #1 each of the respective mitogens per culture; 0.5 #Ci 
of [3H]thymidine was added  18 h before harvesting. The frequency of polyclonal Igosecreting 
cells in splenocyte populations was determined by a reverse hemolytic plaque assay in which 
SRBC coated with rabbit anti-mouse IgM,tc were developed with a rabbit anti-mouse Ig and 
guinea pig complement (14). 
Results 
Survival Rate.  The median  survival times  (Fig.  1)  of unmanipulated  MRL/Mp- 
lpr/lpr and MRL/Mp-+/+  mice were  160  and 510 d, respectively. Of these control 
lpr/lpr mice,  100%  developed grossly apparent lymphoid hyperplasia and dermatitis 
as previously described  (1-3).  The lymphoid hyperplasia became evident  clinically 
when  the  animals were  -3.5  mo of age and progressed thereafter until  death.  The 
lpr/lpr  mice  thymectomized  and  subsequently  transplanted  with  +/+  thymuses 
retained  the disease phenotype of the unmanipulated lpr/lpr mice, including lymph 
node  hyperplasia  and  a  50%  mortality  at  186  d.  The  +/+  mice  were  similarly 
unchanged  by thymectomy and  transplation  with lpr/lpr thymuses; these mice did 
not develop lymphoid hyperplasia and 50% remained alive at 498 d  of age, which is 
not appreciably different than that of the unmanipulated controls. In contrast, lpr/lpr 
mice successfully thymectomized when newborn but not transplanted with thymuses 
did not develop lymph node hyperplasia or dermatitis, and  100% of them were alive 
by the 13 mo of age, a point well beyond the 90% death rate of control, unmanipulated 
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FIG.  1.  Survival  rates of thymectomized and of thymus-transplanted MRL mice.  Numbers in 
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lpr/lpr mice (9 mo of age). Of a  total of 20 thymectomized, untransplanted  animals, 
10 mice in apparently good health and without lymphoid hyperplasia were killed at 
13 mo of age for histologic and cellular studies (see below). The remaining 10 animals 
are still alive and under observation. 
Histolic Observations.  About 90% (Table II) of control, unmanipulated lpr/lpr mice 
had  severe  glomerulonephritis  by  the  5th  mo.  Similarly,  ~80%  of  lpr/lpr  mice 
thymectomized and transplanted  with  +/4-  thymus developed severe glomerulone- 
phritis by 5 mo. In contrast, only  10% of the thymeetomized, untransplanted  lpr/lpr 
mice  that  were  killed  at  13  mo  of age  had  developed  severe  glomerulonephritis. 
Approximately 30-40%  of the  +/+  thymectomized mice transplanted  with  lpr/lpr 
thymus had severe glomerulonephritis  at  the time of death  (12-24 mo old).  Of the 
remaining animals one-half died of pneumonia without  glomerulonephritis,  and  in 
the other one-half the cause was undetermined. 
Histologically, hyperplasia and proliferation were evident in the lymph nodes of all 
unmanipulated as well as thymectomized and +/+  thymus-transplanted lpr/lpr mice, 
but in none of the successfully thymectomized untransplanted animals. Identically to 
unmanipulated  +/+  mice, +/+  mice thymectomized and transplanted with lpr/lpr 
thymus had little or no lymphoid hyperplasia at the time of death. 
Serologic Characteristics.  Serologically, the lpr/lpr recipients of +/+  thymus and the 
+/+  recipients of lpr/lpr thymus behaved like the unmanipulated  respective groups; 
hypergammaglobulinemia,  high  levels  of anti-ssDNA  and  anti-dsDNA  antibodies, 
retroviral gpT0, immune complexes, and BUN were observed in the former, but not 
the  latter  recipients  (Table  III).  However,  thymectomized,  untransplanted  lpr/lpr 
mice  had  significantly  reduced  levels  in  each  of these  categories  compared  with 
unmanipulated controls (P <0.001, Student's t test). 
Cellular Characteristics.  As indicated above, thymectomized, untransplanted lpr/lpr 
mice did not develop the characteristic lymph node hyperplasia observed upon gross 
examination  of their 4-5-mo old  unmanipulated  counterparts.  Approximately 6  × 
108-7  ×  10  a cells were recoverable from mesenteric lymph nodes of a  diseased 5-too- 
old unmanipulated lpr/lpr mouse or an lpr/lpr mouse thymectomized and transplanted 
with +/+  thymus, and -90% of these cells were Thy- 1.2 antigen positive (Table IV). 
In  comparison,  successfully thymectomized,  untransplanted  lpr/lpr  mice  that  were 
killed  had  mesenteric,  inguinal,  and  submaxillary nodes similar in  size to those  in 
TABLE  II 
Relationship between the Thymus and Glomerulonephritis in MRL Mice 
Degree of glomerulonephritis 
0  1  +  2  +  3  +  4  + 
% 
lpr/lpr (unmanipulated) (10)*  0  0  10.0  50  40 
+/+ thymus ~  lpr/lpr Tx~: (24)  8.3  12.5  0  37.5  41.6 
lpr/lpr thymus ~  +/+ Tx (10)  30.011  20.011  20.0  20.0  10.0 
lpr/lpr Tx (no implant) (10)§  60.0  20.0  10.0  0  10.0 
* Numbers in parentheses indicate the numbers of mice from  which kidney biopsies were available. 
:~ Tx, thymectomized;  --~, transplanted into. 
§ Successfully thymectomized lpr/lpr mice that were experimentally killed at 13 mo of age. 
]1 +/+ mice without glomerulonephritis that died relatively early had developed  pneumonia. THEOFILOPOULOS, BALDERAS, SHAWLER,  LEE, AND  DIXON  1409 
TABLE  III 
Relationship between the Thymus and Serologic Characteristics of MRL Mice* 
Immune 
IgG  a-ssDNA  a-dsDNA  complexes  gp7O  BUN 
rng/ml  % binding  mg/ml  #g/ml  mg/dl 
lpr/fpr  (unmanipulated)  31.0 ±  5.0§  77.8 ~  10.2  28.6 ±  5.8  2,935A ±  793.5  27.1 ±  38.1  51. t  ±  9.6 
+/+  (unmanipulated)  13.4 :t: 0.9  51.7 ±  13.0  12.5  ±  3.6  67.2:1:32.0  10.7  :[: 2.8  27.0 :[:  10.0 
Ipr/lpr thymus ~  +/+  Tx*  10.8 :[: 1.2  54.6 ±  14.1  15.3  +  8 2  142.0 :l: 87.8  9.5 ±  6.2  222 ±  5.1 
+/+ thynms-'* lpr/Ipr Tx  30.7 +  8.2  82.2 ±  178  36.7 ±  18.3  2,352. l  ±  1,310.2  20.4 ±  8.7  51.0 ±  12.4 
lpr/Ipr Tx (no implant)  11.6 ±  3.1  23.8 ±  14.8  10.4  :l: 3.4  ! 19.0 ±  79.6  7.7  :l: 6.5  27.0 :i: 8.2 
* Sera obtained at 5 mo of age. 
Tx, thymectomized; --~, transplanted  into. 
§ Levels of IgG, anti  (a)-ssDNA, a-dsDNA,  immune complexes, gp70, and  BUN were significantly different  (Student's t  test,  P  <0.001)  in 
thymectomized,  untransplanted  Ipr/lpr mice compared  with unmanipulated controls.  All other experimental  groups were not significantly 
different from their respective c~ntrols. 
TABLE  IV 
Relationship between the Thymus and T Cell Proliferation in Lymphoid Organs of MRL Mice* 
No. cells/MLN~  No. cells/ 
spleen 
X  [0 -6 
lpr/lpr § (unmanipulated)  679 ±  113  287 ± 45 
(91% Thy-l.2  +) 
+/+[[ (unmanipulated)  ND** 
lpr/lpr thymus ---* +/+ Tx§[[  ND 
+/+ thymus§ ~  Ipr/lpr Tx¶  590 ± 210 
(87% Thy- 1.2  +) 
lpr/lpr Tx (no implant)l[  13 ± 8  109 ± 23 
Splenocytes 
Thy-l.2  +  slg  +  Thy- 1.2  +  slg  + 
%  × 10  -6 
67±8  27±5.0  192  77 
81+17  36±5  51±13  29  41 
110±  11  40±9  52±9  44  57 
310±59  74± ll  19±4  229  58 
1l±3  67±9  12  73 
* Results from groups of five animals. 
:~ MLN, mesenteric lymph node; 
§ Tx, thymectomized; ----~,  transplanted  into. 
[[ 13 mo old. 
¶ 5 mo old. 
* * Not done. 
immunologically normal murine strains.  That  is,  only  13  ×  106 cells were recovered 
from  isolated  mesenteric  nodes of such  animals.  Similarly,  thymectomized, untran- 
splanted  lpr/lpr mice did not have the splenomegaly so commonly found in unmani- 
pulated or +/+  thymus-transplanted  4-5-mo-old lpr/lpr animals. As shown in Table 
IV, approximately threefold more mononuclear cells were recovered from spleens of 
unmanipulated or +/+-thymus transplanted mice than from thymectomized, untran- 
splanted  lpr/lpr mice.  Moreover, in the splenocyte populations  from thymectomized 
and,  subsequently,  +/+  thymus-transplanted  as  well  as  in  unmanipulated  lpr/lpr 
mice,  ~70%  of cells  were  positive  for Thy-l.2  antigen  compared with  only  11%  in 
thymectomized, untransplanted  mice.  Conversely, 4-/+  thymus-transplanted  or un- 
manipulated lpr/lpr mice had  19-27% of surface Ig (sIg)-positive cells in their spleens, 
whereas  thymectomized, untransplanted  animals  had 67% of similarly stained  cells. 
Therefore, in absolute numbers,  the spleens and mesenteric lymph nodes of unmani- 
pulated  or +/+  thymus-transplanted  lpr/lpr mice had  ~80-  to 90-fold more T  cells 
than those of thymectomized, untransplanted  lpr/lpr mice. In addition, these thymec- 
tomized, untransplanted  animals  had  ~ 10-fold less spontaneous  Ig-secreting cells in 
their spleens  than  unmanipulated  or +/+  thymus transplanted  lpr/lpr mice  (Table 1410  THYMIC  ROLE  IN  MURINE  SYSTEMIC  LUPUS  ERYTHEMATOSUS 
TABLE V 
Effect of Thymectomy on the Frequency  of Spontaneous Ig-secreting Splenocytes 
of lpr/lpr mice* 
No. IgSC/106 
splenocytes$  Total/spleen 
lpr/lpr (unmanipulated)  §  12,373 ±  674  3,551,051 
lpr/lpr Yxll (no implant)¶  2,998 +  196  326,782 
* Results from groups of five animals (mean :t: SD). 
$ IgSC, Ig-seereting splenocytes. 
§ 5 mo old. 
I1 Tx, thymectomized. 
¶ 13 mo old. 
V). There were no appreciable differences in numbers of either total spleen and lymph 
node cells or Thy-1.2 and sIg-bearing cells between unmanipulated or thymectomized, 
lpr/lpr thymus-transplanted +/+  mice. 
Discussion 
The important and novel point made by these studies pertains to the irrelevance of 
the thymus genotype to the phenotype of autoimmune disease in the MRL strain of 
mice. Our studies  demonstrate  that  the  thymus  must  be present  for expression of 
lymphoid hyperplasia caused by T  cell proliferation and for early SLE in the lpr/lpr 
phenotype of MRL/Mp mice but the genotype of the thymus is irrelevant. Conversely, 
these  experiments  demonstrate  that  differentiation  of +/+  stem  cells  (from  the 
congenic substrain)  to T  cells under the hormonal or microenvironmental influence 
of a  thymus  that  possessess  the  lpr  genotype  does  not  lead  to  abnormal  T  cell 
differentiation  and  early  autoimmunity.  In  addition,  because  early thymectomy 
improved  survival  of lpr/lpr  mice, we  may conclude that  the  B  cell  hyperactivity 
leading to the immune complex-mediated aspects of SLE was dependent upon the 
presence of a thymus and not exclusively caused by either an intrinsic B cell defect or 
mitogenic stimulation that causes polyclonal B cell activation. Our experiments have 
not established whether the T  cell defect associated with the disease is acquired at the 
prethymic or thymic level.  Nor  have  they determined  whether the  thymic effects 
necessary for expression of T  cell proliferation are exerted within the thymic microen- 
vironment or extrathymically via thymic hormones (15), or both. Nevertheless these 
experiments certainly exclude causation of the disease by intrinsic abnormalities of 
the lpr/lpr thymus (hormonal or microenvironmental) because the lpr/lpr early, severe 
SLE  is  not  prevented  or  delayed  by  +/+  thymus  and  transplantation  of lpr/lpr 
thymus to the +/+  mice does not cause T  cell proliferation and early SLE in this 
substrain. After our initial report (i 6) and during the completion of our studies, others 
also reported inhibition of lymphoid hyperplasia and early disease development in 
neonatally thymectomized lpr/lpr mice (17). 
Several other observations indicate the importance of the lpr gene and of associated 
T  cell  proliferation  in  the  development  of early,  severe  SLE  in  MRL  mice.  We 
previously demonstrated that total lymphoid irradiation (TLI) or whole body irradia- 
tion of 3-mo-old lpr/lpr  mice inhibited expression of lymphoid hyperplasia and the 
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whether or not the thymus was shielded during irradiation (A. N. Theofilopoulos, B. 
L.  Kotzin,  and  S.  Strober, unpublished  observation), suggesting  that  the  primary 
defect might be in a radiosensitive prethymic precursor clone that needs the thymus 
to  be  expressed.  The  important  role  of the  lpr  gene  in  T  cell  proliferation,  and 
consequently in the early SLE syndrome, has also been shown in genetic studies (1, 3, 
16,  19). Because Ipr is a  recessive gene, its effects cannot be expressed in F1 hybrids. 
However, when the lpr gene is established in a homozygous state among strains with 
late-developing  disease,  then  early  SLE  develops;  in  +/+  mice,  50%  mortality 
decreases from  17 to 5 mo of age, and in NZB mice the drop is from 16 mo to 5 mo 
(E. D. Murphy and J. D. Roths, personal communication). Using a different approach, 
Cowdery and Steinberg (20)  found that crosses of CBA/N ×  MRL/1  FI males that 
express the xid gene had significantly lower levels of serum IgM than those of female 
littermates,  but  the  presence of xid gene did  not  suppress  spontaneously produced 
antibody to DNA.  In further experiments with backcross males, these investigators 
demonstrated a  direct association between lymphoproliferation (lpr gene) and spon- 
taneous production of large amounts of anti-DNA. The latter results with lpr/lpr mice 
contrasted  with  those obtained by the same  investigators  (20,  21)  and  others  (22) 
when testing NZB backcross males bearing the xid gene and producing very little IgM 
or anti-DNA antibody. 
In contrast to the beneficial effects of thymectomy in lpr/lpr mice, our unpublished 
studies and those of others indicate that neonatal thymectomy accelerated the disease 
of NZB/W mice, especially males (17, 23-25). Moreover, athymic nude NZB/W mice 
developed disease at the same pace and as severely as their nu/+  controls (26). All 
these findings suggest an intrinsic B cell defect or polyclonal B cell activators as the 
responsible agent of disease in NZ mice and questioned the primary importance of 
the  reported  hormonal  (5)  and  cellular  (7,  27)  defects  of the  NZ  thymus  in  the 
development of SLE in  this strain  of mice. These results  highlight  once again  the 
complex pathogenesis of murine SLE and reinforce our earlier proposal (28) that the 
cause and course of this disease in the various strains may rest on individual basic 
defects, different pathways of abnormalities,  and distinct accelerating factors. Such 
an acceleratong factor acting on a background of autoimmune disease that develops 
late in life may modify it to an early-life one (3, 16, 19). The accelerating factors have 
now been defined as the lpr gene in MRL/Mp-lpr/lpr  mice (I, 16-18; this study, and 
studies currently in progress), the Y  chromosome-linked defect in BXSB male mice 
(1,  3,  16,  19,  29,  30),  and  possibly hormonal  influences in  NZB/W  mice  (31).  As 
shown here, thymectomy blocked expression of  the lpr accelerating factor and modified 
this disease of lpr/lpr substrain to a late disease or to no disease at all. 
This study and studies underway strongly suggest that early, severe SLE-like disease 
in  lpr/lpr  mice  is  caused  by abnormal  stem  cells,  which  upon  differentiation in  a 
thymus  (irrespective of its genotype) give rise to proliferating Thy-l.2  +,  Ly-1 ÷ cells 
(12, 32) that accelerate or help the expression of hypergammaglobulinemia, autoan- 
tibody production, and disease. This conclusion is consistent with results of previous 
studies suggesting that the proliferating cells in lpr/lpr mice exert an excessive helper 
function  in  vitro  for  polyclonal  Ig  synthesis  (14)  and  anti-DNA  antibody  (33) 
production. Sequential studies remain to be performed so as to determine the exact 
onset of B cell hyperactivity in this substrain and its relationship to the expression of 
the lpr gene. In other words, it remains still to be ascertained whether expression of 1412  THYMIC  ROLE  IN MURINE  SYSTEMIC LUPUS ERYTHEMATOSUS 
the lpr gene has simply an accelerating effect on a preexisting B cell defect or whether 
it  represents  the  actual  triggering  signal  for  expression  of B  cell  activation  and 
autoantibody production. At any rate, this is certainly the first animal model in which 
a  single genetic defect has such a  profound effect on the development of generalized 
autoimmunity. Congenic strains currently developed with single-gene defects provide 
a superb framework for comparison with normal genes at the same locus, for studying 
their  interrelationship  with  known  genes  that  control  immunoregulation,  and  for 
linking genetic and cellular abnormalities as a whole with autoimmunity. 
Summary 
In  young  adulthood,  MRL/Mp-lpr/lpr  mice  develop  a  severe  systemic  lupus 
erythematosus (SLE)-like syndrome associated with massive T  cell proliferation. The 
congenic MRL/Mp-+/+  mice lack the lpr gene and develop chronic SLE late in life. 
We have exchanged thymic transplants between these substrains so as to determine 
the role of the thymus in the development of early, severe SLE and of lymphoproli- 
feration.  The median survival times of unmanipulated  lpr/Ipr and  +/+  mice were 
160 and 510 d, respectively. The lpr/lpr and +/+  mice thymeetomized when newborn 
and  transplanted  at  1 mo with  the  opposite  type of thymus  retained  the  diseases 
phenotype of their unmanipulated  counterparts with 50% mortality at  186 and 498 
d,  respectively.  In  contrast,  lpr/lpr  mice  thymectomized  when  newborn  but  not 
transplanted  with  thymus did not  develop lymphoid hyperplasia and glomerulone- 
phritis, and  100% of them were alive at 390 d. SerologicaUy, the thymectomized but 
untransplanted lpr/lpr mice had significantly reduced levels of autoantibodies, whereas 
thymectomized and transplanted mice of either substrain were similar to unmanipu- 
lated controls.  The results  indicate  that:  (a)  a  thymus  is  essential  for expression of 
lymphoproliferation and early SLE-like disease in the lpr/lpr phenotype;  (b) the lpr/ 
lpr disease is not a result of a unique hormonal or microenvironmental defect(s) of the 
thymus  of this  substrain  because  the  genotype of the  thymus  is  irrelevant  for the 
development of T  cell proliferation  and early SLE;  (c)  differentiation of +/+  stem 
cells under the hormonal or microenvrionmental influences of a thymus that possesses 
the lpr genotype does not lead to abnormal T  cell differentiation or early autoimmu- 
nity;  and  (d)  the lpr/lpr disease cannot be caused exclusively by an  intrinsic  B  cell 
defect or environmental stimuli that cause B cell polyclonal activation. 
We thank Ms. P. J. McConahey for the gp70 determinations and Ms. L. A. Flores and Ms. P. 
Minick for excellent  secretarial and editorial assistance. 
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